The impact of renal histopathological findings on anemia in patients with biopsy-proven diabetic nephropathy

The impact of renal histopathological findings on anemia in patients with biopsy-proven diabetic nephropathy - Hb decline in diabetic nephropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012847

Enrollment

100

Registered

2014-01-30

Start date

2014-01-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with diabetes mellitus who underwent renal biopsy at our hospital and were confirmed to have diabetic nephropathy according to Tervaert's classification(J Am Soc Nephrol. 2010;21(4):556-63)

Exclusion criteria

Exclusion criteria: Transplanted kidney Coexistence of other renal diseases except for nephrosclerosis Hemoglobin level<11g/dl at the time of renal biopsy eGFR<15mL/min/1.73m2 at the time of renal biopsy Less than 12 months of follow-up periods treatment with erythropoietin stimulating agent at the time of renal biopsy

Design outcomes

Primary

Measure	Time frame
hemoglobin decline	—

Countries

Japan

Contacts

Public ContactKoki Mise

Toranomon Hospital Kajigaya Nephrology Center

kokims-frz@umin.ac.jp044-877-5111

Outcome results